Renal Denervation Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Renal Denervation Catheters Market Report Overview
The Renal Denervation Catheters market size was valued at $52.8 million in 2023. The market is anticipated to witness strong growth at a CAGR of more than 26% during 2023-2033. Renal Denervation or Renal Sympathetic Denervation (RSD) is a minimally invasive catheter-based endovascular procedure. The procedure utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in nerve activity that ultimately reduces the blood pressure in resistant hypertension patients.
Renal Denervation Catheters Market Outlook, 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Renal Denervation Catheters Market Forecast
The Renal Denervation Catheters market research report has been created to understand the market behavior, which will help identify quantitative market trends within the Endoscopy Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Renal Denervation Catheters market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2023) | $52.8 Million |
CAGR (2023-2033) | >26% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Radiofrequency Catheters
· Ultrasound Catheters · Micro-infusion Catheters |
Leading Companies | · Medtronic Plc
· Boston Scientific Corp · ReCor Medical Inc · Abbott Laboratories |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Renal Denervation Catheters Market Dynamics
The Renal Denervation Catheters market will grow owing to the high prevalence of hypertension and, the usefulness of the treatment for resistant hypertensive patients. In addition, the usefulness of Renal Denervation Catheters as a potential treatment option for conditions such as sleep apnea, heart failure, arrhythmias, and even moderate hypertension will also boost its demand in the coming years. However, the lack of reimbursement in many countries and the high cost of the device and the procedure may limit the market growth.
Renal Denervation Catheters Market Segmentation by Regions
The key regions in the Renal Denervation Catheters market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. In 2023, North America dominated the overall Renal Denervation Catheters market. The successful clinical trials of devices in the US will result in significant growth of the market in the projected period.
Renal Denervation Catheters Market Analysis, by Regions 2023 (%)
Buy the Full Report for More Insights into the Regions in the Renal Denervation Catheters Market
Renal Denervation Catheters Market Segments
The key segments in the Renal Denervation Catheters market are Radiofrequency Catheters, Ultrasound Catheters, and Micro-infusion Catheters. The Radiofrequency Catheters segment led the market in 2023.
Renal Denervation Catheters Market Analysis, by Segments 2023 (%)
Buy the Full Report for More Insights into the Segments in the Renal Denervation Catheters Market
Renal Denervation Catheters Market - Competitive Landscape
A few of the leading companies in the Renal Denervation Catheters market are:
- Medtronic Plc
- Boston Scientific Corp
- ReCor Medical Inc
- Abbott Laboratories
Medtronic Plc dominated the market in 2023. It is followed by Boston Scientific Corp.
Renal Denervation Catheters Market Analysis, by Companies 2023 (%)
Buy the Full Report for More Insights into the Companies in Renal Denervation Catheters Market
Segments Covered in the Report
Renal Denervation Catheters Segments Outlook (Value, $ Million, 2015-2033)
- Radiofrequency Catheters
- Ultrasound Catheters
- Micro-infusion Catheters
Renal Denervation Catheters Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed Renal Denervation Catheters and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Renal Denervation Catheters market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Renal Denervation Catheters market.
- Competitive dynamics insights and trends provided for the Renal Denervation Catheters market.
Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Boston Scientific Corp, Abbott laboratories, Otsuka Holdings Co Ltd, and Others.
Countries covered: United States, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Russia, Austria, Greece, Sweden, Switzerland, Australia, China, India, Japan, South Korea, Brazil, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Renal Denervation Catheters market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Renal Denervation Catheters market.
- Competitive dynamics insights and trends provided for the Renal Denervation Catheters market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on the Renal Denervation Catheters market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Renal Denervation Catheters market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Renal Denervation Catheters market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Renal Denervation Catheters market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Frequently asked questions
-
What was the Renal Denervation Catheters market size in 2023?
The Renal Denervation Catheters market size was $52.8 million in 2023.
-
What will the Renal Denervation Catheters market growth rate be during the forecast period?
The Renal Denervation Catheters market is expected to grow at a CAGR of more than 26% during 2023-2033.
-
Which region dominated the Renal Denervation Catheters market?
North America dominated the overall Renal Denervation Catheters market in 2023.
-
Which segment led the Renal Denervation Catheters market in 2023?
The Radiofrequency Catheters segment led the market in 2023.
-
Which are the leading companies in the Renal Denervation Catheters market?
A few of the leading companies in the Renal Denervation Catheters market are Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, and ReCor Medical Inc. among Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.